Fen-Phen Litigation

Represented individuals who suffered heart valve damage and/or a life-threatening condition known as primary pulmonary hypertension (PPH) from ingestion of fenfluramine manufactured by American Home Products Corporation (AHP).  In total, we represented eight individuals with PPH and 31 individuals who had heart valve damage or who were required to have their heart valve surgically replaced with a mechanical valve.  We conducted discovery applicable to all of our cases in one lead PPH case and one lead heart valve case, both filed in State Court in Minnesota.  The lead cases were both settled prior to trial, and shortly thereafter a global settlement was reached with AHP for the balance of our cases.